Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, V5A1S6, Canada.
Department of Chemistry, Simon Fraser University, Burnaby, British Columbia, V5A1S6, Canada; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, V5A1S6, Canada.
Curr Opin Struct Biol. 2021 Jun;68:157-165. doi: 10.1016/j.sbi.2020.12.008. Epub 2021 Jan 31.
O-linked N-acetylglucosamine (O-GlcNAc) is protein modification that is emerging as a regulator of diverse aspects of cellular physiology. Aberrant O-GlcNAcylation has been linked to several diseases, spurring the creation of methods to detect and perturb the activity of the two enzymes that govern this modification - O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Here we summarize assays used for these two enzymes. We also detail the latest structure-guided development of inhibitors of these two enzymes and touch on selected reports that underscore the utility of inhibitors as tools for uncovering the diverse roles of O-GlcNAc in cell function. Finally, we summarize recent reports on the potential therapeutic benefits of antagonizing these enzymes and comment on outstanding challenges within the field.
O-连接的 N-乙酰葡萄糖胺(O-GlcNAc)是一种蛋白质修饰,它作为细胞生理学多个方面的调节剂而崭露头角。异常的 O-GlcNAcylation 与几种疾病有关,这促使人们创造了检测和干扰控制这种修饰的两种酶的方法-O-GlcNAc 转移酶(OGT)和 O-GlcNAcase(OGA)。在这里,我们总结了用于这两种酶的测定方法。我们还详细介绍了最新的基于结构的这两种酶抑制剂的开发,并提到了一些强调抑制剂作为揭示 O-GlcNAc 在细胞功能中的多种作用的工具的有用性的报告。最后,我们总结了最近关于拮抗这些酶的潜在治疗益处的报告,并评论了该领域的悬而未决的挑战。